Global segment ranking · Healthtech › Medtech
The world’s most valuable connected devices startups
Connected health and medical devices: wearables and smart rings, remote patient monitoring, continuous glucose and heart monitors, connected stethoscopes and home exam kits, brain-computer interfaces and connected neurotechnology. Ranked worldwide by AI-estimated valuation, with listed pure players shown in grey at their market value for reference. The market sets the value; AI models estimate it.
Key metrics for this segment: key milestone. Figures as published by each company or the press, dated, not recalculated. The AIs weigh them alongside funding history and comparables.
Not in this segment. Listed, so not ranked: DexCom, Insulet and Owlet (shown in grey), and iRhythm, Tandem Diabetes Care, Beta Bionics, Senseonics, Masimo and Zepp Health. Not ranked here: Noise (consumer electronics), surgical robots and implants without a data focus, and image-reading AI (under Imaging & medical AI, such as DentalMonitoring and Omniscient Neurotechnology). A company appears in one segment only. Method
The segment at a glance
30companies ranked
2companies on the radar
10countries in the ranking
3listed benchmarks
Sources: Company announcements, Bloomberg, Reuters, TechCrunch, Fierce Biotech, MassDevice, MedTech Dive, STAT, Sifted, 36Kr, TechNode, Inc42 and market data for listed companies. Intention counters will be shown above a threshold of amount and number of Backers.
Rankings by region
Filter the ranking and the Radar. Ranks stay worldwide. Regional pages: Asia · Europe · Middle East & North Africa · North America.Global ranking · Connected devices
Snapshot28 Oct 2026A snapshot taken on 28 Oct 2026
This ranking shows the startups as they stood on 28 Oct 2026. Funding rounds, valuations and other events announced after that date are not included yet. They will be taken into account in the next edition, scheduled for 25 Mar 2027.
Spotted a more recent round? Tell us →First edition: no movements yet.
This ranking shows the startups as they stood on 28 Oct 2026. Funding rounds, valuations and other events announced after that date are not included yet. They will be taken into account in the next edition, scheduled for 25 Mar 2027.
Spotted a more recent round? Tell us →First edition: no movements yet.
World · 30 ranked companies
| # | Company | Last round · Key metrics | AI valuation | Pool of InterestsInterest: a free, non-binding declaration on a company, or on a sector within an area, made during the free phase of a pool. Pool: all the Interests declared on the same target. This column shows the number of Backers and the combined amount of their tickets, to validated members only. Terms for Backers → | BackBacking a startup on Uback (pronounced “you back”) can be done in two ways: Interest · free: a non-binding declaration that signals your demand for a company or a sector. You can move or withdraw it at any time, with up to 5 at once. Intention · coming soon: a paid, confirmed declaration, still non-binding. Once its pool reaches critical mass, it is presented to a company by a partner desk. Neither is an order nor a commitment to invest. Terms for Backers → |
|---|---|---|---|---|---|
| — | DexComListed · Nasdaq · DXCM | USD 32bnMarket cap · Oct 2026Listed company · not ranked | |||
| 1 | OuraMakes a smart ring and subscription app that track sleep, activity, heart rate, temperature and women's health signals for consumers, employers and health partners. | Series E · USD 900M · Oct 20255.7M paying members; FY2025 revenue USD 907.9M · Sep 2026 | Last known equity round: Series E · USD 900M · Oct 2025 (Fidelity Management & Research; ICONIQ, Whale Rock, Atreides) Published valuation: USD 11bn (Oct 2025)Method |
Be the first | Back |
| — | InsuletListed · Nasdaq · PODD | USD 11bnMarket cap · Oct 2026Listed company · not ranked | |||
| 2 | Whoop#45 in the United StatesSubscription wearable strap that tracks strain, recovery, sleep and heart metrics, giving athletes and consumers coaching through a companion app and health features. | Series G · USD 575M · Mar 2026Key metrics not disclosed | Last known equity round: Series G · USD 575M · Mar 2026 (Collaborative Fund, Qatar Investment Authority, Mubadala, 2PointZero) Published valuation: USD 10bn (Mar 2026)Method |
Be the first | Back |
| 3 | Neuralink#51 in the United StatesDevelops a fully implanted wireless brain-computer interface that lets people with paralysis control computers and devices with their thoughts, implanted by a dedicated surgical robot. | Series E · USD 650M · Jun 2025Key metrics not disclosed | Last known equity round: Series E · USD 650M · Jun 2025 (ARK Invest, Founders Fund, Sequoia Capital, Thrive Capital) Published valuation: USD 9bn (Jun 2025)Method |
Be the first | Back |
| 4 | BiofourmisProvides remote patient monitoring and care-at-home services combining wearable biosensors with AI analytics for health systems, payers and pharmaceutical trials. | Series D · USD 300M · Apr 2022Key metrics not disclosed | Last known equity round: Series D · USD 300M · Apr 2022 (General Atlantic; CVS Health)Method | Be the first | Back |
| 5 | Science CorpDevelops neural engineering devices including the PRIMA retinal implant that restores some vision to people blinded by macular degeneration, alongside broader brain-computer interface research. | Series C · USD 230M · Mar 2026Key metrics not disclosed | Last known equity round: Series C · USD 230M · Mar 2026 (Lightspeed, Khosla Ventures, Y Combinator, In-Q-Tel) Published valuation: USD 1.5bn (Mar 2026)Method |
Be the first | Back |
| 6 | Eight SleepSells the Pod, a temperature-controlled mattress cover with sensors that track sleep and heart and breathing signals and adjust cooling or heating automatically using AI. | Strategic · USD 50M · Mar 2026Free-cash-flow positive in 2025; ships to over 34 countries · Mar 2026 | Last known equity round: Strategic · USD 50M · Mar 2026 (Tether Investments) Published valuation: USD 1.5bn (Mar 2026)Method |
Be the first | Back |
| 7 | BrainCoDevelops non-invasive brain-computer interface products, including EEG headbands and AI-powered bionic hands and legs controlled by muscle and neural signals, for rehabilitation and consumers. | Late stage · USD 287M · Jan 2026Key metrics not disclosed | Last known equity round: Late stage · USD 287M · Jan 2026 (IDG Capital, Walden International)Method | Not open to BackersCompanies based in mainland China are ranked like any other startup, but Uback does not open pools on them: capital controls and offshore (VIE) structures make minority deals impractical for our Backers. You can still declare an interest in this segment → |
|
| 8 | SynchronDevelops the Stentrode, a brain-computer interface implanted through blood vessels that lets people with paralysis control digital devices by thought without open brain surgery. | Series D · USD 200M · Nov 2025Stentrode implanted in 10 patients in US and Australian trials · Nov 2025 | Last known equity round: Series D · USD 200M · Nov 2025 (Double Point Ventures; ARCH Venture Partners, Khosla Ventures, Bezos Expeditions, NTI)Method | Be the first | Back |
| 9 | Blackrock NeurotechMakes the Utah array-based implantable brain-computer interface systems used to let people with paralysis control robotic arms and computers and decode speech from brain signals. · Controlled by Tether | Strategic (majority stake) · USD 200M · Apr 2024Key metrics not disclosed | Last known equity round: Strategic (majority stake) · USD 200M · Apr 2024 (Tether Evo)Method | Be the first | Back |
| 10 | Precision NeuroscienceDevelops the Layer 7 thin-film cortical interface, a minimally invasive brain implant that records and stimulates neural activity to restore communication and control for paralysed patients. | Series D · USD 250M · Sep 2026Key metrics not disclosed | Last known equity round: Series D · USD 250M · Sep 2026 (Pershing Square, Ackman Oxman Institute; Duquesne Family Office, B Capital, ARK Invest, Invus) Published valuation: USD 1bn (Sep 2026)Method |
Be the first | Back |
| 11 | Merge LabsResearches non-invasive brain-computer interfaces that use molecules and ultrasound instead of electrodes to exchange information with neurons, aiming to connect human and artificial intelligence. | Seed · USD 250M · Jan 2026Key metrics not disclosed | Last known equity round: Seed · USD 250M · Jan 2026 (OpenAI; Bain Capital, Interface Fund, Fifty Years, Gabe Newell) Published valuation: USD 850M (Jan 2026)Method |
Be the first | Back |
| 12 | NeuracleDevelops invasive and non-invasive brain-computer interface systems, including the NEO implant that lets spinal-cord-injury patients control devices, plus neural research equipment for hospitals and labs. | Pre-IPO · Dec 2025NEO implantable BCI approved by NMPA; 2025 revenue about RMB 108M · Mar 2026 | Last known equity round: Pre-IPO · Dec 2025 (China Merchants China Investment, Pudong Venture Capital) Published valuation: USD 560M (Dec 2025)Method |
Not open to BackersCompanies based in mainland China are ranked like any other startup, but Uback does not open pools on them: capital controls and offshore (VIE) structures make minority deals impractical for our Backers. You can still declare an interest in this segment → |
|
| 13 | BiolinqDevelops an intradermal wearable glucose sensor patch worn on the forearm that measures glucose just beneath the skin and shows results without a phone for people with diabetes. | Series C · USD 100M · Apr 2025Key metrics not disclosed | Last known equity round: Series C · USD 100M · Apr 2025 (Alpha Wave Ventures; RiverVest Venture Partners, AXA IM Alts, LifeSci Venture Partners, M Ventures)Method | Be the first | Back |
| 14 | NeuroXessDevelops invasive brain-computer interface systems using flexible high-density electrodes for speech decoding and motor restoration in patients with paralysis and neurological disorders. | Series B · USD 98.6M · Oct 202665 clinical cases; registration trial in ~20 hospitals launched Jul 2026 · Oct 2026 | Last known equity round: Series B · USD 98.6M · Oct 2026 (SDIC Juli, Shenzhen Capital Group, Qinzhi Capital)Method | Not open to BackersCompanies based in mainland China are ranked like any other startup, but Uback does not open pools on them: capital controls and offshore (VIE) structures make minority deals impractical for our Backers. You can still declare an interest in this segment → |
|
| 15 | Cala HealthMakes prescription wrist-worn neuromodulation devices that deliver personalised nerve stimulation to reduce hand tremor in people with essential tremor and Parkinson's disease. | Series D · USD 77M · 2022FDA clearance of Cala kIQ Plus wearable · Apr 2026 | Last known equity round: Series D · USD 77M · 2022Method | Be the first | Back |
| 16 | StairMedDevelops a high-channel-count wireless invasive brain-computer interface implanted by its own surgical robot, aiming to let paralysed patients and amputees control devices by thought. | Strategic · USD 72.8M · Apr 2026Three clinical implants of 256-channel wireless BCI; 40 implants targeted in 2026 · Apr 2026 | Last known equity round: Strategic · USD 72.8M · Apr 2026 (Alibaba; Tencent, Fountainbridge Capital, OrbiMed, Oriza Seed)Method | Not open to BackersCompanies based in mainland China are ranked like any other startup, but Uback does not open pools on them: capital controls and offshore (VIE) structures make minority deals impractical for our Backers. You can still declare an interest in this segment → |
|
| 17 | SiBionicsMakes continuous glucose monitoring sensors with a smartphone app for people with diabetes, and develops other implantable and AI medical devices such as retinal prostheses. | Series D · USD 72M · Dec 2022Key metrics not disclosed | Last known equity round: Series D · USD 72M · Dec 2022 (Shanghai HealthCare Capital, Guangdong Chinese Medicine Healthcare Capital; Industrial Securities Capital, Next Capital, China New Town)Method | Not open to BackersCompanies based in mainland China are ranked like any other startup, but Uback does not open pools on them: capital controls and offshore (VIE) structures make minority deals impractical for our Backers. You can still declare an interest in this segment → |
|
| 18 | UltrahumanDesigns the Ultrahuman Ring and other wearables plus at-home blood testing and app-based metabolic and sleep insights for consumers tracking their health. | Series D · USD 60M · Sep 2026Key metrics not disclosed | Last known equity round: Series D · USD 60M · Sep 2026 (Qualcomm Ventures; Alpha Wave Global, Labcorp, Blume Ventures, Nexus Venture Partners) Published valuation: USD 360M (Sep 2026)Method |
Be the first | Back |
| 19 | WithingsDesigns connected health devices such as smart scales, ECG watches, blood pressure monitors and a home urine analyser, with apps and remote-monitoring services for consumers and clinicians. | Series B · USD 60M · Jul 2020Key metrics not disclosed | Last known equity round: Series B · USD 60M · Jul 2020 (Gilde Healthcare, Eurazeo, Bpifrance, BNP Paribas)Method | Be the first | Back |
| 20 | Natural Cycles#21 in SwedenOffers an FDA-cleared digital birth control and fertility app that uses temperature data from thermometers, smart rings, watches and its own band to identify fertile days. | Series C · USD 55M · May 2024Key metrics not disclosed | Last known equity round: Series C · USD 55M · May 2024Method | Be the first | Back |
| 21 | KernelDevelops wearable non-invasive brain-measurement headsets using time-domain functional near-infrared spectroscopy to quantify brain activity for research and clinical studies. | Series C · USD 53M · Jul 2020Key metrics not disclosed | Last known equity round: Series C · USD 53M · Jul 2020 (General Catalyst, Khosla Ventures, Eldridge)Method | Be the first | Back |
| 22 | INBRAIN Neuroelectronics#26 in SpainDevelops graphene-based brain-computer interfaces and neural implants that read and modulate brain signals to treat neurological disorders such as Parkinson's disease. | Series B · USD 50M · Oct 2024Key metrics not disclosed | Last known equity round: Series B · USD 50M · Oct 2024 (imec.xpand, EIC Fund, ICO Next Tech)Method | Be the first | Back |
| 23 | BioIntelliSenseMakes the BioButton, a medical-grade wearable that continuously measures vital signs and feeds data to clinicians for hospital and at-home remote patient monitoring. | Series B · USD 45M · Jul 2021Key metrics not disclosed | Last known equity round: Series B · USD 45M · Jul 2021 (Chimera; 7wire Technology Partners, Mary Tolan, James Murren, Pendrell)Method | Be the first | Back |
| 24 | Eko HealthMakes AI-enabled digital stethoscopes and ECG-equipped devices that help clinicians detect heart murmurs, atrial fibrillation and low ejection fraction during routine exams. | Series D · USD 41M · Jun 2024FDA clearance of AI for low ejection fraction detection · Apr 2024 | Last known equity round: Series D · USD 41M · Jun 2024 (ARTIS Ventures, Highland Capital Partners, NTTVC, Questa Capital)Method | Be the first | Back |
| 25 | ParadromicsDevelops Connexus, a high-data-rate implantable brain-computer interface designed to restore communication for people with ALS, spinal cord injury or stroke by decoding neural signals. | Series A · USD 33M · May 2023FDA Breakthrough Device designation for Connexus; first-in-human trial planned · May 2023 | Last known equity round: Series A · USD 33M · May 2023 (Prime Movers Lab; Westcott Investment Group, Dolby Family Ventures, Green Sands Equity)Method | Be the first | Back |
| — | OwletListed · NYSE · OWLT | USD 150MMarket cap · Sep 2026Listed company · not ranked | |||
| 26 | TytoCareSells a handheld remote examination kit with camera, stethoscope and thermometer attachments plus AI tools, letting clinicians examine patients at home through telehealth visits. | Growth · USD 25M · Jul 2026FDA-cleared AI wheeze detection (Tyto Insights) for remote asthma monitoring · Aug 2023 | Last known equity round: Growth · USD 25M · Jul 2026 (Insight Partners)Method | Be the first | Back |
| 27 | Clinics On CloudClinics On Cloud makes self-service Health ATM kiosks for preventive health check-ups and connected microclinics for hospitals, pharmacies, companies and government bodies. | Series A · USD 12.5M · Nov 2026Key metrics not disclosed | Last known equity round: Series A · USD 12.5M · Nov 2026 (Model42, Enlightened Minds Investments) Published valuation: USD 75M (Nov 2026)Method |
Be the first | Back |
| 28 | Flow NeuroscienceSells a home brain-stimulation headset using transcranial direct current stimulation, paired with a behavioural therapy app, to treat depression under clinical supervision. | Series A · USD 9.3M · Aug 2021Key metrics not disclosed | Last known equity round: Series A · USD 9.3M · Aug 2021 (Khosla Ventures, CSS Group, Zühlke Ventures; Kirin Holdings, SOSV HAX, Schox)Method | Be the first | Back |
| 29 | Neurosoft BioelectronicsDevelops soft, stretchable brain-computer interface electrodes that rest on the cortex surface without penetrating tissue, for recording and stimulating brain activity in neurological conditions. | Seed · USD 7.5M · May 2026Key metrics not disclosed | Last known equity round: Seed · USD 7.5M · May 2026 (Skybound Venture Capital; PL Capital, IAG Capital Partners, Connecticut Innovations)Method | Be the first | Back |
| 30 | Esper Bionics#10 in UkraineBuilds an AI-powered prosthetic hand that learns its user's muscle signals and connects to an app, giving amputees adaptive, data-driven upper-limb prosthetics. | Seed · USD 5M · Jun 2024Key metrics not disclosed | Last known equity round: Seed · USD 5M · Jun 2024 (YZR Capital, EBRD, u.ventures)Method | Be the first | Back |
Back · Backing on Uback (pronounced “you back”) means declaring an Interest (free) or an Intention (coming soon). Backing does not mean that this company is raising funds or that a shareholder is selling shares, and it is not a commitment to invest. Any deal, through a funding round or a sale by an existing shareholder, is handled by a partner desk: the Fundraising Desk of the country for a round, the Secondary Sales Desk assigned to the company for a sale. · Terms
Corporate investor? Back the startups of your own segment
No ranked company in this region yet: see the Radar.
Ranking in descending order of AI-estimated valuation, based on public information, with no human intervention on the order. The valuations, ranges and brackets shown are editorial estimates produced by AI, purely indicative and imperfect by nature: neither a financial valuation, nor an offer, nor investment advice. Only the market sets a company’s value, through a funding round or a sale. Ranking established by Claude (Anthropic) from public information, following the published rules. A consensus of several AIs will apply from 1 December 2026. Eligibility: at least $1M raised in equity, non-listed company, main activity in this segment (connected devices). Country shown is the country of main operations. Request a correction · Full method →
Get every new ranking
New entries, exits and movements, at every edition.
No data passed on to third parties. See our Privacy policy.
Challengers
A registered company raising funds that is not in the ranking will be able, for a fee, to appear in a separate list labelled “Challengers”, for a set period, with a memo available to verified Backers. The listing has no effect on the ranking. Not open yet.
Sponsored space · no Challenger listed yet
Radar · known eligible companies, not ranked
Sorted by date of last round, with no judgement and no AI call.
No company on the radar in this region yet.
Listed benchmarks
Not ranked: no intention is possible on a listed company.
Sources and method for this segment
Calendar. Global segment rankings are published twice a year. Next edition: March 25, 2027.
Eligibility. At least $1M raised in equity, non-listed company, main activity in this segment (connected devices). A company appears in one segment only.
Sources. Company announcements, Bloomberg, Reuters, TechCrunch, Fierce Biotech, MassDevice, MedTech Dive, STAT, Sifted, 36Kr, TechNode, Inc42 and market data for listed companies.